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UNIT 4.11Synthesis and Purification of Peptide Nucleic
Acids
Peptide nucleic acids (PNAs) are DNA analogs in which the normal phosphodiester
backbone is replaced by 2-aminoethyl glycine linkages (Fig. 4.11.1). In spite of this
significant chemical modification, the hybridization of PNAs with DNA or RNA follows
normal rules for Watson-Crick pairing and occurs with high affinity. The fact that PNAs
possess a dramatically different backbone and bind efficiently has created enormous
interest in their application.
This unit describes the synthesis and purification of PNAs. PNAs can be synthesized using
either automated procedures (see Basic Protocol 1; Mayfield and Corey, 1999) or manual
procedures (see Basic Protocol 2; Norton et al., 1995). The goal here is to provide the
reader with the basic information necessary to initiate experiments with PNAs.
NOTE: It is essential that the reagents used for PNA synthesis, whether automated or
manual, be kept as anhydrous as possible, because contamination with water will result
in incomplete coupling of monomers during synthesis.
BASIC
PROTOCOL 1
AUTOMATED SYNTHESIS OF PEPTIDE NUCLEIC ACIDS
The automated synthesis of PNAs is illustrated in Figure 4.11.2. Automated synthesis is
a convenient strategy for obtaining PNAs, and is performed using the Expedite synthesizer
(Applied Biosystems). This instrument has been specially adapted for PNA synthesis,
with proprietary software for FMOC chemistry instead of the phosphoramidite chemistry
used for typical oligonucleotide synthesis. It is probably possible to adapt other synthe-
sizers for PNA synthesis; however, the investigator will need to consider whether the
number of PNAs needed justifies the time and expense required to adapt the instrumen-
tation.
The reagents used are available from Applied Biosystems separately or as an Expedite
PNA kit. Two resins are available: a xanthen alkonic acid (XAL) resin and a peptide amide
linker (PAL) resin. Although either is adequate for automated synthesis, the XAL resin
is preferred because the cleavage step is considerably shorter (5 min according to Applied
Biosystems, compared to 90 min for the PAL resin). 
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Figure 4.11.1 Structure of a peptide nucleic acid.
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2-Aminoethoxy-2-ethoxy acetic acid (AEEA) is used as a linker molecule for PNA
synthesis. A linker molecule is used to introduce a controlled space between PNAs or
between a PNA and some other functional or spatially addressable large group, such as
rhodamine or biotin. Linked PNAs (bis-PNAs) possess an enhanced ability to bind by
strand invasion and are an important tool for recognition of duplex DNA. Linker coupling
is often inefficient, so it is always done two times.
Although the synthesis described here is an automated process, this does not excuse the
experimenter from closely monitoring the various steps throughout the synthesis. Careful
observation to ensure proper machine function can result in catching errors as they occur
and allow manual intervention that can rescue the synthesis and prevent loss of reagents
and time (see Critical Parameters).
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Figure 4.11.2 Automated PNA synthesis as described in Basic Protocol 1. Abbreviations: Ac2O, acetic anhydride; base*,
N-protected nucleobase (see PNA monomers); BHOC, benzhydryloxycarbonyl; DIPEA, diisopropylethylamine; DMF, N,N-
dimethylformamide; FMOC, 9-fluorenylmethoxycarbonyl; HATU, O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium
hexafluorophosphate; NMP, N-methylpyrrolidone; P, FMOC-XAL-PEG-polystyrene; TFA, trifluoroacetic acid.
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Materials
PNA Expedite reagents (Applied Biosystems)
 FMOC-PNA monomers (Fig. 4.11.2): 9-fluorenylmethoxycarbonyl-protected 
 peptide nucleic acid monomers (A, T, C, and G), base protected with    
 benzhydryloxycarbonyl (BHOC)
 Diluent: N-methylpyrrolidone (NMP)
 Activator: 7-aza-1-hydroxybenzotriazole (HOAt) or            
 O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
 (HATU)
 Linker: 2-aminoethoxy-2-ethoxy acetic acid (AEEA)
 Base solution: 0.2 M diisopropylethylamine (DIPEA)/0.3 M 2,6-lutidine
 Deblocking solution: 20% (v/v) piperidine in N,N-dimethylformamide (DMF)
 Capping solution: 5% (v/v) acetic anhydride/6% (v/v) 2,6-lutidine in DMF
N,N-Dimethylformamide (DMF), anhydrous (Burdick Jackson; wash A is
Opti-Dry DMF from Fisher; wash B is anhydrous DMF from Applied
Biosystems)
Amino acids (Novabiochem, Advanced Chemtech)
Isopropyl alcohol (optional)
Cleavage cocktail: 20% (v/v) m-cresol (Sigma-Aldrich) in trifluoroacetic acid
(TFA; Burdick Jackson)
Diethyl ether, –20°C
Expedite 8909 synthesizer (Applied Biosystems)
FMOC-XAL-PEG-PS synthesis column (0.2 µmol prepacked; Applied
Biosystems)
10-mL syringe
1.5-mL, 0.2-µm polytetrafluoroethylene (PTFE) or regenerated cellulose spin
column (Millipore)
Additional reagents and equipment for automated synthesis (see manufacturer’s
instructions) and for purification and analysis of PNAs (see Basic Protocol 3)
NOTE: Powdered reagents such as monomers, activator, and linker (AEEA) should be
unpacked on arrival and stored at –20°C in a sealed container containing Drierite
desiccant. Monomers should be inspected upon arrival. Clumps of reagent may indicate
that water has been introduced during shipping.
NOTE: The authors use three sources of DMF because the bottles from Fisher (Opti-Dry)
and Applied Biosystems fit onto the input fitting and reagent port on the synthesizer, and
the third can be used following synthesis. All DMF must be anhydrous and should have
a low amine content to reduce the likelihood of side reactions. DMF should be purchased
in 100-mL volumes to ensure that it is used quickly, minimizing the likelihood that
contaminating water will interfere with synthesis.
Prepare reagents
1. Dry all powdered reagents in vacuo overnight prior to solubilizing.
Although the authors have found that drying in vacuo is most necessary during humid
weather, it is always a worthwhile precaution.
2. Warm amber bottles in which FMOC-PNA monomers were shipped to room tem-
perature prior to solubilization to prevent water from condensing inside the container.
3. Solubilize FMOC-PNA monomers by adding 3.25 mL NMP diluent directly to each
amber bottle (final 216 mM monomer). Allow the mixture to sit undisturbed for 30
min at room temperature.
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Premature vortexing of the monomer at this point will cause partially dissolved clumps of
monomer to stick to the side of the bottle. If this occurs, extra time should be taken to bring
the clumps to the bottom of the bottle. Typically, monomers A, T, and G do not require
vortexing, and a gentle swirling of the bottle’s contents will suffice. Solubilization of
monomer C often requires some assistance. Intermittent heating of monomer C in a shallow
water bath at 37°C can assist in solubilization, as can occasional vortexing or sonication.
The authors have also diluted the C monomer in an additional 0.5 mL of NMP and have
observed that this facilitates dissolving the reagent without decreasing synthesis yield.
Experimenters should note that solubility can be dependent on the lot number of PNA
monomer; some lots can be more or less difficult to dissolve than others. 
The volumes indicated for reagent solubilization (steps 3 to 5) are adequate for 37 cycles,
but the volumes prepared must ultimately accommodate the specific sequences and cou-
pling events required for a given synthesis. Each cycle requires 90 L monomer, 90 L
activator, 90 L base, 1.2 mL deblocking solution, 2.39 mL DMF wash A, 36 L DMF wash
B, and 300 L capping solution. These volumes are estimates. The investigator should
always load significantly more reagent on the synthesizer to ensure that no reagent runs
out during the final coupling steps.
4. Dissolve PNA activator (HOAt or HATU) in 13.5 mL anhydrous DMF (final 182
mM).
Although HOAt is generally less expensive, it is also less efficient as a coupling reagent
than HATU, which was developed specifically for PNA synthesis. HOAt should only be used
for shorter sequences (≤12 couplings). HATU has been used for syntheses requiring >40
couplings.
5. Dissolve AEEA linker in 2.4 mL NMP diluent (final 209 mM).
Perform PNA synthesis
6. Load the above reagents as well as base solution, amino acids, deblocking solution,
and capping solution onto an Expedite 8909 synthesizer with an FMOC-XAL-PEG-
PS column.
Monomers, activator, and linker should not remain on the machine for >2 weeks. Amino
acids should not be left on the machine for >2 days due to their tendency to crystallize.
Amino acids are the least expensive reagent and it is cost effective to replace these solutions
frequently rather than risk failed syntheses or damage to the instrument.
7. Perform synthesis according to manufacturer’s programs and specifications, stopping
before removal of the final FMOC group.
It is critical that the final FMOC be left on the PNA until a decision has been made to cleave
the PNA from the resin or add another group. If synthesis is complete and the PNA is to be
cleaved from the resin, proceed to step 9.
8. Optional: Perform any desired manual additions (e.g., see Support Protocols 1 and
2).
9. Implement the final deblock option in the prime menu of the Expedite PNA software.
Cycle the final deblock procedure one time to complete the double deblock procedure.
Wash and prepare PNA-bound resin
10. Remove the column from the synthesizer and wash four times with 10 mL DMF,
reversing the direction of flow through the column each time.
11. Wash the column four times with 10 mL isopropyl alcohol, reversing the direction of
flow through the column each time to facilitate drying of the resin.
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12. Dry the resin in vacuo for a minimum of 30 min or by blowing filtered house air
across the column for 3 to 5 min, reversing the ends frequently.
Resin is sufficiently dry when the resin plug slides easily from end to end as the air input
is reversed.
Cleave PNA from solid-phase resin
13. Transfer the dried, resin-bound, deprotected PNA to a 1.5-mL, 0.2-µm PTFE or
regenerated cellulose spin column.
14. Add 250 µL cleavage cocktail and incubate 90 min at room temperature.
Although cleavage of PNAs from the FMOC-XAL-PEG-PS resin occurs in 5 min, cleavage
of the protecting groups on the PNA side-chains requires at least 90 min. Complete cleavage
of the BHOC side chains can be verified by MALDI-TOF mass spectrometry. Incomplete
cleavage will result in a mass that exceeds the expected value by increments of the BHOC
mass (100.1). Also, in the authors’ experience, products that retain one or more protecting
groups will have longer retention times by RP-HPLC (the protecting groups are hydropho-
bic).
Uniform cleavage is dependent on the freshness of the TFA, while the m-cresol serves as a
molecular scavenger. The quality of the TFA can be checked by observing the color of the
solution. It should be clear to slightly yellow. If the color progresses to a more orange-
brown color, it should not be used for cleavage, but may still be used in preparing RP-HPLC
buffer A (see Basic Protocol 3). In addition to solution color, TFA should release a small
amount of fume (smoke) when the container is opened. If this is not observed, it should not
be used for any procedure involving PNAs.
CAUTION: TFA is caustic and should be dispensed using only glass pipets or pipet tips
containing a charcoal filter (Intermountain Scientific). The charcoal filter serves as a
barrier that protects the pipettor seals from the TFA fumes.
15. Centrifuge 2 min at 1300 × g for a PTFE filter or 2 min at 8400 × g for a regenerated
cellulose filter.
16. Repeat steps 14 and 15, but reduce cleavage time to 5 min.
17. Collect the cleavage filtrate, remove the filter unit, and precipitate the PNA by adding
1 mL cold (–20°C) diethyl ether. Invert the tube several times to ensure complete
precipitation.
If the synthesis has been successful, the precipitated PNA should be obvious.
18. Centrifuge precipitated PNA 2 min at 1300 × g. Discard the supernatant.
19. Wash the pellet three times with 1 mL diethyl ether, vortexing to suspend the pellet.
20. Centrifuge 2 min at 8400 × g to repack the pellet.
Centrifugation speeds of more than 8400 × g should be avoided because tight packing of
PNA makes it difficult to dissolve the pellet.
21. Remove as much of the supernatant as possible by aspiration and then air dry the
pellet for 5 to 10 min in a chemical fume hood.
22. Hydrate the pellet with 200 µL sterile water (for a 2-µmol synthesis) and allow the
tube to remain undisturbed for 10 to 15 min at 65°C.
Only slight vortexing should be required to complete PNA solubilization.
23. Purify and analyze PNA (see Basic Protocol 3).
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SUPPORT
PROTOCOL 1
ADDING PEPTIDES TO PNAS
The addition of peptide sequences to PNAs is a convenient method for obtaining
conjugates in which the peptide domain enhances hybridization (Zhang et al., 2000) or
cell uptake (Simmons et al., 1997) of the attached PNA . Peptides can be added to a PNA
in a number of ways. If the peptide contains three or fewer different amino acids, it can
be conveniently added immediately before or after automated synthesis using the three
open ports on the Expedite 8909 synthesizer in addition to the four dedicated to PNA
monomers. All amino acids should be double coupled since amino acid coupling is
sometimes inefficient. Also, since amino acids are inexpensive relative to PNA monomers,
generous use of amino acids during coupling is a cost-effective strategy for optimizing
synthesis yields.
If more than three different amino acids need to be added, it is often more convenient to
contract a dedicated peptide synthesis facility to add the completed peptide. In this case,
it is recommended that the first amino acid of the peptide be coupled to the newly
synthesized PNA prior to shipping the resin. The authors have found that this procedure
reduces the likelihood of the N terminus becoming blocked during shipping and storage.
The synthesis of the PNA should be coordinated with the facility that will add the peptide,
so that delays between syntheses are avoided. Delay between syntheses can result in the
spontaneous loss of FMOC groups, exposing the N terminus to modification and prevent-
ing its extension. The facility adding the peptide should be instructed to double or triple
couple the first amino acid that is added at their facility. Prior to shipping, the column
should be washed with DMF and dried in vacuo overnight.
The thiol group of cysteine provides a convenient reactive group for PNA modification.
Additional care is required to adequately cleave PNAs or PNA conjugates containing
sulfhydryl groups, as the authors and others (Goodwin et al., 1998) have noted that the
sulfhydryl can be modified during deprotection and purification. To avoid modification
of cysteine, the cleavage cocktail should be supplemented with 7.5 mg pure crystalline
phenol (Fisher) and 250 µL ethanedithiol (Sigma-Aldrich) per 1 mL of cleavage cocktail.
Cysteine-containing PNAs should be neutralized immediately after purification to avoid
the formation of TFA adducts. Neutralization can be achieved by adding 0.5 mL of an
aqueous solution of 0.1 M ammonium acetate to the RP-HPLC fraction collection tube
prior to collecting the PNA fraction. Incomplete neutralization will result in a product
that is 97 mass units higher than expected, corresponding to an adduct with TFA.
SUPPORT
PROTOCOL 2
ADDITION OF BIOTIN
Once a PNA is synthesized, fluorescent groups, biotin, or other labels can be added to the
free N terminus prior to deprotection. The labeling of PNAs with biotin is described as
an example.
Additional Materials (also see Basic Protocol 1)
Biotin (Sigma)
42°C water bath
1-mL syringe
1. Perform a normal automated PNA synthesis (see Basic Protocol 1, steps 1 to 8).
2. Dissolve 20 mg biotin, 6.1 mg HATU, and 1.4 mg HOAt in 800 µl DMF. Warm the
solution to 42°C and vortex intermittently until completely dissolved.
Biotin is not readily soluble and will require warming and vortexing. Due to its poor
solubility, biotin solutions should never be put on the synthesizer, as it will clog the lines.
3. Add 200 µL PNA base solution and mix well. Allow components to activate for 5
min at 42°C.
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4. Remove N-terminal FMOC group by performing the final two deblock cycles to
remove the N-terminal cap of the resin-bound PNA (see Basic Protocol 1, step 9).
5. Wash the column two times from each end with 10 mL DMF.
6. Draw up the biotin solution into a 1-mL syringe and place into one end of the column.
7. Place a second syringe into the other end of the column and push the solution back
and forth for 30 min.
8. Repeat steps 5 to 7 with another 1-mL preparation of biotin solution.
Addition of biotin is repeated because of the inherently poor coupling efficiency of biotin.
9. Proceed to the procedure for cleavage of PNAs from solid-phase resin (see Basic
Protocol 1, steps 10 to 23).
BASIC
PROTOCOL 2
MANUAL SYNTHESIS OF PEPTIDE NUCLEIC ACIDS
The manual synthesis of PNAs is illustrated in Figure 4.11.3. Manual synthesis of PNAs
is advantageous because PNAs can be obtained in larger amounts (>2 µmol) than on the
Expedite synthesizer. By changing the amount of resin used, one can prepare as much or
as little PNA as needed for each experiment. Manual synthesis also avoids the need for a
dedicated automated synthesizer. As with automated synthesis, it is important to keep
reagents and materials as anhydrous as possible. However, the coupling reactions are more
exposed to atmospheric water. The authors have found that syntheses that use tert-butyl-
oxycarbonyl (BOC) monomers generally produce better yields than syntheses using
FMOC monomers.
Manual PNA synthesis is often so efficient that a capping step can be dispensed with. It
is sometimes advisable, however, to include a capping step after coupling of the monomer
to simplify the HPLC purification. The individual experimenter will have to determine
the necessity for capping. It is typically necessary for long syntheses or for syntheses that
have failed in the past.
Many different types of apparatus can be used for manual peptide synthesis, and it is likely
that these can be adapted for PNA synthesis. The apparatus described here (Fig. 4.11.4;
Norton et al., 1995) uses common laboratory glassware and offers robust performance.
While the details of manual synthesis will vary with apparatus, the outline of the procedure
and the precautions that need to be taken will remain the same. Because a single missed
step can ruin a labor-intensive synthesis, the authors follow a detailed checklist for each
step. The checklist provides a written record that all steps were performed. A sample
spreadsheet detailing the amount of reagent needed for synthesis is shown in Figure
4.11.5.
Materials
Nitrogen source
N,N-Dimethylformamide (DMF; OptiDry; Fisher)
4-Hydroxymethylphenylamidomethyl (PAM) resin protected with
tert-butyloxycarbonyl (BOC; Applied Biosystems)
Carrier resin: PAM resin capped with an acetyl group (see Support Protocol 3)
BOC-PNA monomers (Fig. 4.11.3; Applied Biosystems):
tert-butyloxycarbonyl-protected peptide nucleic acid monomers (A, C, G, and
T), base protected with benzyloxycarbonyl
2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate
(HBTU) and 1-hydroxybenzotriazole (HOBt) activators (Applied Biosystems)
Fresh dichloromethane (DCM; Fisher)
m-Cresol
Trifluoroacetic acid (TFA; Burdick Jackson)
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Pyridine
Diisopropylethylamine (DIPEA)
Methanol
Thioanisole
Trifluoromethanesulfonic acid (TFMSA; Aldrich)
Diethyl ether, ice cold
250°C oven
125-mL vacuum filtration side-arm flasks
24/40 rubber septa
15-mL medium (C) fritted Pyrex funnel
Vacuum tubing
3-way valves
250-mL Wheaton bottles with caps
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Figure 4.11.3 Manual PNA synthesis as described in Basic Protocol 2. Although a capping step can be
added, it is often not required and is not shown here. Abbreviations: base*, N-protected nucleobase (see
PNA monomers); BOC, tert-butyloxycarbonyl; Bn, benzyl; DIPEA, diisopropylethylamine; DMF, dimethyl-
formamide; HBTU, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophospate; HOBt, 1-
hydroxybenzotriazole; P, PAM resin; TFA, trifluoroacetic acid; TFMSA, trifluoromethanesulfonic acid.
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A
lysine
Monomer
Molecular Weight
g/mol
PNA mass after each coupling
g/mol
C-Terminus
1
2
3
4
5
6
7
8
9
10
11
12
13
N-Terminus
A Monomer
G Monomer
C Monomer
T Monomer
HBTU
HOBt
DIPEA
DMF
5.0
Equivalents
5.0
5.0
5.0
4.5
5.0
10.0
–
17.41 mg
Amount Per Coupling
17.94 mg
16.62 mg
12.68 mg
11.26 mg
4.46 mg
8.54 µL
Up to 1 mL
14
terminal amide
A
17.00
128.00
275.32
275.32
251.30
275.32
291.32
275.32
266.28
266.28
291.32
291.32
291.32
275.32
266.28
–
145.00
420.32
695.64
946.94
1222.26
1513.58
1788.90
2055.18
2321.46
2612.78
2904.10
3195.42
3470.74
3737.02
Total Mass 3737.02
C
A
G
A
T
T
G
G
G
A
T
Amount of Resin Used
Substitution Number for Resin
Total Active Sites
PNA Mass
Amount of PNA to be Synthesized
10 mg
0.66 mmol/g
0.0066 mmol
3737.02 mg/mmol
24.6 mg
Figure 4.11.5 Example of a spreadsheet for the manual synthesis of a 14-base PNA including
lysine at the C terminus. The resin used produces a theoretical yield of 24.6 mg of PNA upon
cleavage.
vacuum
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coupling
flask
deprotection
flask
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Figure 4.11.4 Apparatus for manual synthesis. Reprinted from Norton et al. (1995) with permis-
sion from Elsevier Science.
Current Protocols in Nucleic Acid Chemistry Supplement 8
4.11.9
Synthesis of
Modified
Oligonucleotides
and Conjugates
Lyophilizer
10-mL flask with a ground glass joint
Desiccator
Additional reagents and equipment for purification and analysis of PNAs (see
Basic Protocol 3)
NOTE: All powdered reagents such as monomers and activator should be unpacked on
arrival and stored at –20°C in a sealed container containing Drierite desiccant. Monomers
should be inspected upon arrival. Clumps of reagent may indicate that water has been
introduced during shipping. DMF should have a low amine content to reduce the
likelihood of side reactions.
Dry reagents and supplies
1. Dry all monomers and coupling reagents overnight in vacuo before beginning
synthesis.
To prevent accumulation of moisture, BOC-PNA monomers that have been refrigerated
should be warmed to room temperature before opening.
2. Dry all glassware, pipet tips, and 1.5-mL microcentrifuge tubes in a 250°C oven
overnight prior to use. Flush pipet tips and microcentrifuge tubes with nitrogen to
ensure they are dry prior to synthesis.
Set up apparatus
3. Clear a work area in a chemical hood.
4. Fit rubber septa over the tops of two 125-mL side-arm flasks and make a single hole
in the middle of each septum to allow a 15-mL fritted funnel to be inserted without
too much force.
5. Assemble the manual synthesis apparatus as in Figure 4.11.4 using vacuum tubing
and 3-way valves such that the vacuum and nitrogen bubbling can be easily manipu-
lated on and off.
6. Ensure that the 15-mL fritted funnel is clean and unclogged. Pull 5 mL DMF through
the funnel to make sure it drains quickly.
Prepare reagents
7. In a 1.5-mL microcentrifuge tube, weigh out the appropriate amount of BOC-pro-
tected PAM resin and add enough carrier resin to give ∼50 mg total resin weight.
The purpose of the carrier resin is to facilitate handling of the resin by allowing researchers
to handle larger volumes.
The amount of PNA to be synthesized is dependent on the amount of resin used and the
number of active sites on the resin. The number of active sites is based on the substitution
number (Fig. 4.11.5), which should be listed on the resin bottle when purchased. The total
number of active sites is based only on the amount the BOC-protected (noncarrier) PAM
resin, as the carrier resin has been capped and contains no active sites.
PAM resin can also be purchased with the first amino acid already attached (Advanced
Chemtech).
8. Load 1.5-mL microcentrifuge tubes with the proper amount of dry monomer for each
coupling reaction. Use a 5-fold excess of monomer over the resin active sites.
It is easiest to set up a spreadsheet (Fig. 4.11.5) with quantities of monomers, HBTU, HOBt,
and DIPEA used for each activation/coupling reaction, checking them off during synthesis
of the PNA.
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9. For each coupling reaction, measure out a 5-fold excess of HOBt (relative to resin
active sites), a 4.5-fold excess of HBTU, 10 eq DIPEA, and 1 mL DMF. Draw DMF
from the bottle using a syringe under nitrogen or argon gas to keep it as anhydrous
as possible.
HOBt, HBTU, DIPEA, and DMF will be added to the monomer in each microcentrifuge
tube just minutes before starting the coupling reaction (step 17). This method is the most
efficient way of activating the monomers, and thus preventing deletions in the final product.
Aldrich sells DMF in Sure/Seal bottles, which have a rubber opening on a crimped lid so
that a syringe can be inserted without uncapping the bottle and exposing the contents to
air. A nitrogen-filled balloon may also be inserted through the rubber opening to continu-
ally flush the bottle with nitrogen during the synthesis.
10. Prepare 200 mL fresh 50:50 (v/v) DMF/DCM for washing. Also prepare 100 mL of
5% (v/v) m-cresol/TFA and 100 mL pyridine in separate clean, dry 250-mL Wheaton
bottles with caps.
The pyridine is used to wash the resin with the base prior to coupling.
CAUTION: TFA is caustic and should be dispensed using only glass pipets or pipet tips
containing a charcoal filter (Intermountain Scientific). The charcoal filter serves as a
barrier that protects the pipettor seals from the TFA fumes.
11. Assemble disposable glass pipets and bulbs, one for each reagent, and place near or
on each reagent bottle.
For convenience and to prevent contamination, the authors usually tape a test tube onto
each bottle as a pipet holder.
12. Place the 15-mL fritted funnel into the deblocking flask. Wet the rubber septum and
the funnel with a little methanol to help it slide in.
13. Add the dry resin to the 15-mL fritted funnel without solubilizing it in DMF.
It is easier to get it all in this way.
Perform synthesis
14. Swell resin in 1 mL DMF for 1 hr with nitrogen bubbling.
15. Close and bleed vacuum line.
16. Add 1 mL of 5% m-cresol/TFA to begin deprotection. Stir 3 min with nitrogen
bubbling.
17. While the BOC group is being removed, activate (esterify) the first monomer to be
added by adding HOBt, HBTU, DMF, and DIPEA (from step 9) to the monomer tube
(step 8). Vortex until everything has gone into solution.
Typically, these solutions turn a tan color after vortexing. Failure to change color can
sometimes be an indication that the activation step is not proceeding properly.
As the synthesis progresses, liquid will accumulate in the flasks. It is important to watch
the level of liquids in the coupling and deprotection flasks and empty them when the volumes
approach the fritted funnel. The deprotection flask can be emptied during a coupling step
and vice versa.
18. Vacuum off deblocking solution from the resin.
19. Wash resin two times with 1 mL of 50:50 DMF/DCM.
20. Close and bleed vacuum line.
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21. Remove funnel from the deprotection flask and insert into the rubber septum over
the coupling flask.
22. Add activated monomer to resin and mix 20 min, with nitrogen bubbling, to couple
the monomer to the resin (or growing PNA).
23. Vacuum off solution.
24. Wash six times with 1 mL of 50:50 DMF/DCM.
25. Wash with 1 mL pyridine then with 1 mL dry DMF.
If capping is necessary, add 1 mL of 1:1 (v/v) acetic anhydride/DMF to the resin and mix
for 20 min. Wash well with DMF and proceed to the next step.
26. Vacuum off solution.
27. Close and bleed vacuum line.
28. Remove funnel from the coupling flask and insert into the septum over the deblocking
flask.
29. Repeat steps 16 to 28 for remaining monomer additions.
30. Remove the final protecting group as in steps 15 and 16.
31. Vacuum off deblocking solution.
32. Wash six times with 1 mL of 50:50 DMF/DCM.
33. Wash six times with 1 mL methanol.
34. Lyophilize overnight.
When the synthesis is complete, it is customary to wash the resin with methanol and to dry
in vacuo overnight before the cleavage is carried out.
If the synthesis takes >1 day, it will be necessary to store the resin. Stop the synthesis just
prior to deblocking the PNA, leaving the protecting group on. Wash the resin several times
with HPLC-grade methanol. Remove the funnel with the resin from the coupling flask, put
a Kimwipe over the top, and secure it with a rubber band. Label the funnel and put it in a
desiccator. Resume the synthesis the following day by starting with swelling of the resin in
NMP and deblocking the PNA (steps 14 to 16).
Cleave PNA from resin
35. Connect a clean 125-mL vacuum flask to the synthesis apparatus in place of the
coupling flask.
36. Attach a rubber septum over the top of the flask and insert the funnel that contains
the resin.
37. Prepare 4 mL cleavage cocktail in a clean, dry 10-mL flask that has a ground glass
joint. Mix 1 part m-cresol, 1 part thioanisole, and 6 parts TFA. Cap the flask, put on
gloves and a shield, crack open a vial of TFMSA, and add 2 parts TFMSA.
Typically, the cleavage cocktail turns brown at this point.
CAUTION: TFMSA is corrosive and extremely destructive to mucous membranes, the
upper respiratory tract, eyes, and skin. Avoid skin contact and inhalation. Always use
suitable protection.
38. Using a pipettor, add 1 mL cleavage cocktail to the resin. Using a very small flow of
nitrogen into the flask, allow solution to barely bubble for ∼1 hr.
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39. Turn off the nitrogen and apply a vacuum to pull the cleavage solution into the clean
flask. Remove as much of the cleavage solution as possible before proceeding to the
precipitation.
Excess TFA will make it more difficult to precipitate the PNA. Excess TFA can be removed
from the solution by blowing a steady stream of nitrogen into the flask until most of the
solution is gone, or by applying a vacuum to the flask for several minutes.
40. With most of the cleavage solution gone, add ≥45 mL ice-cold diethyl ether to the
flask and set it on ice.
41. Take a spatula and scrape the sides of the flask to loosen all of the PNA into solution.
There should be a white precipitate in the solution.
42. Pour the PNA/diethyl ether solution into a 50-mL conical centrifuge tube, cap tightly,
and centrifuge 3 min at 1040 × g (e.g., 2500 rpm in a Beckman S4180 swinging bucket
rotor), 5°C, pelleting the PNA to the bottom of the tube.
43. Carefully decant or aspirate off the diethyl ether.
44. Wash pellet three times by adding 50 mL ice-cold diethyl ether to the tube, vortexing,
centrifuging, and removing the supernatant.
45. After decanting the last time, place a Kimwipe over the tube containing the well-
washed pellet and place it in a desiccator. Attach the house vacuum and allow PNA
to dry overnight.
46. Purify and analyze PNA (see Basic Protocol 3).
The PNA can be stored at −20°C as a lyophilized product or as an aqueous stock solution
(in deionized water). Traces of TFA will slightly acidify the solution and readily dissolve
the PNA.
SUPPORT
PROTOCOL 3
PREPARATION OF CARRIER RESIN FOR MANUAL PNA SYNTHESIS
Carrier resin is prepared by deprotecting a simple BOC-protected PAM resin and
performing a capping step using acetic anhydride.
Additional Materials (also see Basic Protocol 2)
tert-Butyloxycarbonyl-protected 4-hydroxymethylphenylamidomethyl resin (e.g.,
BOC-Ala-PAM, BOC-Val-PAM, BOC-Ile-PAM; Applied Biosystems)
Acetic anhydride
HPLC-grade dichloromethane
HPLC-grade methanol
1. Set up the manual synthesis apparatus (Fig. 4.11.4) with a single flask.
2. Place ∼2 g BOC-protected PAM resin in the fritted funnel and swell with 1 mL DMF
for 1 hr.
3. Vacuum off DMF.
4. Add a large excess (e.g., 1 mL) of 5% (v/v) m-cresol/TFA and deprotect the resin for
10 min with bubbling.
5. Wash two times with 1 mL DMF and repeat deprotection two more times.
The resin should be fully deprotected at this point.
6. Wash five times with 1 mL DMF and once with 1 mL pyridine.
7. Add 1 mL of 1:1: (v/v) acetic anhydride/DMF and bubble for 20 min.
8. Wash once with 1 mL DMF and repeat step 7.
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9. Wash once each with 1 mL DMF, 1 mL dichloromethane, and 1 mL methanol.
10. Dry overnight in a desiccator.
The resin can be prepared in bulk and stored at 4°C in the desiccator.
BASIC
PROTOCOL 3
PURIFICATION AND ANALYSIS OF PEPTIDE NUCLEIC ACIDS
PNAs can be purified by reversed-phase HPLC (RP-HPLC) followed by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) (Fig.
4.11.6). PNAs are not, however, purified or analyzed by standard procedures used for
oligonucleotides. PNA purification and analysis is more similar to that for peptides. 
Materials
PNA sample solution (see Basic Protocols 1 and 2)
RP-HPLC buffer A: 0.1% (v/v) trifluoroacetic acid (TFA; Burdick Jackson) in
water, passed through a 47-mm, 0.4-µm nylon membrane (Whatman)
RP-HPLC buffer B: 0.1% (v/v) TFA in acetonitrile (Optima grade; Fisher), filtered
through an Anodisc 47 filter (0.22-µm; Whatman)
α-Cyano-4-hydroxycinnamic acid (Sigma)
Isopropanol
High-performance liquid chromatograph (HPLC) with C18 reversed-phase column
(300-Å Microsorb-MV column; Varian Analytical Instruments)
Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass
spectrometer (Voyager-DE workstation; Applied Biosystems)
Lyophilizer
UV spectrophotometer
Additional reagents and equipment for HPLC and MALDI-TOF-MS
BA
Retention time (min) Mass (amu)
100
%B
80
60
m.w. 5144.58
5
9.
26
1
9.
91
0
10
.1
81
10
.4
18
10
.0
73
11
.1
53
12
.3
58
40
20
0
3.
17
1
4.
89
8
Figure 4.11.6 Typical (A) HPLC and (B) MALDI-TOF mass spectrometry data.
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Purify by HPLC
1. Centrifuge a PNA solution 3 min at 12,000 × g, room temperature, to remove
particulate.
2. Heat a C18 reversed-phase HPLC column to 55°C.
PNAs tend to form internal structure or higher order aggregates; sharper peaks will often
be obtained if the column is maintained at 55°C using a heated water jacket.
3. Set up a gradient of 0% to 5% (v/v) RP-HPLC buffer B in buffer A for 6 min followed
by 5% to 100% buffer B in buffer A for 24 min.
4. Inject sample.
5. Collect fractions corresponding to major peaks.
Analyze by MALDI-TOF-MS
6. Spot a 1-µL aliquot of each HPLC fraction on the laser target of a MALDI-TOF mass
spectrometer.
7. Overlay the sample with 1 µL matrix consisting of 10 mg/mL α-cyano-4-hydroxy-
cinnamic acid in 25:75 (v/v) RP-HPLC buffers A/B.
8. Activate the laser and collect data.
Resolution is best when lower laser energies are used (∼1400 mV) but higher energies are
sometimes necessary, especially with long PNAs and PNA-peptide conjugates.
Analytical scale analysis by HPLC or mass spectral analysis of the crude product often
reveals that only one product has been formed. If this is the case, the PNA can be
conveniently purified by Sep-Pak Vac 6-mL (1 g) C18 cartridge (Waters Chromatography).
Alternatively, PNAs can be purified by preparative C18 HPLC (Baker Bond, J.T. Baker).
PNAs typically elute between 32% and 37% RP-HPLC buffer B and are routinely >80%
full-length material.
Solubilize and store PNA
9. Pool collected fractions containing the PNA with the appropriate mass. Freeze in an
isopropanol/dry ice bath and lyophilize.
PNAs that are not to be used immediately can be stored indefinitely in a lyophilized form
at –20°C in a sealed storage box containing desiccant.
10. Dissolve the resulting pellet in 200 µL sterile water and allow the tube to sit 5 to 10
min undisturbed at room temperature.
PNAs are readily soluble in aqueous solutions at pH 5.0 to 6.0 at high concentrations
(millimolar) but are less soluble at higher pH’s. Solubility at neutral pH can be enhanced
by the incorporation of charged amino acid residues at the termini of PNAs during
synthesis. Heating solutions containing PNAs can also enhance solubility, and the authors
recommend always heating PNAs to >50°C immediately prior to use to ensure that
aggregation is minimized.
The authors have repeatedly frozen and thawed solubilized PNAs without observing
diminished hybridization, although for long-term storage it is best to store PNAs in
lyophilized form.
Analyze by UV spectrophotometry
11. Heat PNA stock solutions 5 min at 65°C to reduce aggregation prior to dilution and
measurement.
PNAs readily aggregate because they are relatively hydrophobic. Heating is a convenient
way to ensure that the measured concentration reflects the total concentration of PNA in
the sample. Repeated heating of PNA samples does not affect their activity.
12. Observe the optical density at 260 nm (typically a 1:500 dilution).
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13. Determine the concentration using the following equation:
 c (mM) = (A260 × 30 ng/µL × 500)/mol. wt.
where 30 ng/µL is the extinction coefficient, 500 is the dilution factor, and mol. wt.
is the molecular weight of the PNA.
Alternatively, the concentration can be determined as a cumulative function of the extinc-
tion coefficients of the PNA monomers. While more time-consuming, the latter method is
more accurate since it is based on the extinction coefficient for a specific PNA sequence.
The authors have found that it yields concentrations that vary by as much as 50% to 60%
from those derived from use of the standard conversion factor. To determine the concentra-
tion using extinction coefficients, add up the extinction coefficients for the PNA sequence
[A =13.7, C = 6.06, G = 11.7, T= 8.6, mL/mol(cm)]. Calculate the OD260/mL of crude
PNA and divide by the total extinction coefficient to obtain the millimolar concentration.
Determination of melting temperature provides a useful functional analysis for PNAs. A
clean melting curve ensures that the PNA is present in solution at the anticipated concen-
tration and can hybridize to its target sequences. The Tm value also provides important
information for optimizing annealing conditions and interpreting results.
COMMENTARY
Background Information
Peptide nucleic acids (PNAs; Nielsen et al.,
1991) are DNA analogs that have a neutral
amide backbone (Fig. 4.11.1) and possess
physical properties that differ from those pos-
sessed by nucleic acids with traditional phos-
phodiester or phosphorothioate backbones. Al-
though they hybridize with high affinity to
DNA and RNA according to normal Watson-
Crick base-pairing rules (Egholm et al., 1993),
the neutral backbone eliminates the electro-
static repulsion that characterizes the hybridi-
zation of DNA and RNA strands. PNA hybridi-
zation to single-stranded DNA or RNA occurs
with high affinity, and hybridization to duplex
DNA is characterized by an outstanding poten-
tial for strand invasion (Smulevitch et al., 1996;
Lohse et al., 1999; Nielsen, 2001). The absence
of a negatively charged backbone also reduces
the likelihood that PNAs will associate with
cellular proteins (Hamilton et al., 1996) and
generate misleading phenotypes. Another dif-
ference relative to DNA or RNA is that the
strength of PNA hybridization is independent
of salt concentration.
Given the many nucleic acid derivatives
available, why should researchers consider us-
ing PNAs? PNAs possess distinctive chemical
properties that confer numerous favorable
properties, including high-affinity binding,
rapid rates of hybridization, efficient strand
invasion, resistance to digestion by nucleases
and proteases, and low propensity to bind to
proteins. PNAs do not spontaneously enter cul-
tured cells, but can be introduced through sim-
ple transfection protocols (Hamilton et al.,
1999; Herbert et al., 1999; Braasch and Corey,
2001; Doyle et al., 2001). PNA synthesis is
efficient and versatile and PNAs can be readily
purified by HPLC and characterized by mass
spectral analysis. Most PNAs will be less sol-
uble than DNA or RNA, but lower solubility
can be overcome by adjusting the pH of stock
solutions or by heating PNA solutions prior to
use. Learning how to obtain and work with
PNAs is not trivial, but the power of PNA
recognition amply justifies the effort for many
applications. Advantages and disadvantages of
PNAs are summarized in Table 4.11.1.
PNAs can also be purchased directly from
Applied Biosystems. Other vendors throughout
the world have been licensed to sell PNAs.
Currently, international vendors include Nip-
pon Flour Mill, Omgen, Sawady Technologies,
and OSWEL-University of Southhampton. Ap-
plied Biosystems can supply information for
the vendor most convenient to a particular labo-
ratory. Obtaining PNAs from commercial
sources will probably be a less expensive option
for laboratories that require a limited number
of PNAs on a 2-µmol scale, especially if the
laboratories do not have experience making
peptides.
Critical Parameters
The solid-phase synthesis of PNAs uses pro-
tocols similar to those developed for peptide
synthesis and the physical properties of PNAs
are more similar to hydrophobic peptides than
to DNA or RNA. PNA solubility at neutral pH
is relatively low, and PNAs tend to aggregate
upon storage. These properties can pose prob-
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lems for researchers unfamiliar with PNAs, and
methods for obtaining useful concentrations of
soluble PNA will be discussed below. The
authors have not found poor solubility to be a
major barrier to experiments with PNAs since
the solubility of PNAs is a pH-dependent prop-
erty. PNAs are soluble to high concentrations
at pH ≤5.0, and usually remain soluble at neu-
tral pH when diluted to lower concentrations or
when pH is slowly adjusted upward. A substan-
tial advantage is that PNAs can be readily
derivatized by peptides or other groups that can
form a covalent linkage with the free amino
terminus.
For automated synthesis, proper mainte-
nance of the instrument is essential. One com-
mon problem is clogged lines that can lead to
reduced flow rate. Line-filters should be re-
placed monthly on all internal bottles to ensure
that the flow of reagents is consistent for all
syntheses. When bottles are removed or placed
on the instrument, the open lip of each bottle
should be wiped with a clean Kimwipe to pre-
vent cross-contamination of bottles and reduce
wear on the O-ring seals. The O-ring seals
should be replaced every 3 months regardless
of any appearance of physical stress.
Troubleshooting
A PNA that has been correctly synthesized
will usually give rise to predominantly one peak
by HPLC purification. However, PNAs that
possess a high likelihood for forming internal
structure may give rise to multiple peaks. The
potential for multiple peaks can be lessened by
heating the HPLC column at 55°C. If mass
spectral analysis shows that the major peaks
share a single predominant product, multiple
peaks may not be a cause for concern. The most
common problem with PNA synthesis is for-
mation of truncated products.
One cause of failed syntheses is use of re-
agents that are contaminated with water, lead-
ing to a reduction in coupling efficiency. PNA
monomer and activator should be routinely
dried in vacuo prior to synthesis. The authors
also use fresh bottles of solvent, ≤14 days old.
Alternatively, failed sequences could arise
due to problems with automated synthesis or
human error during manual synthesis. If trun-
cated products are formed, the HPLC will show
a series of peaks with shorter retention times
than would be expected for full-length product.
Another problem is failure to fully cleave
protecting groups after completion of synthe-
sis. Since the protecting groups are hydropho-
bic, a failure to cleave them results in products
with longer retention times after RP-HPLC.
PNAs that have this problem will appear to have
at least two peaks upon HPLC analysis and can
be salvaged by a second treatment with TFA
and m-cresol. Retention of FMOC groups can
also be confirmed by observation of a mass of
222 atomic mass units (amu) greater than ex-
pected. To avoid this problem, the authors use
TFA within 1 month of first opening bottles.
The solubility properties of PNA are dis-
cussed above. PNA oligomers have different
solubility properties than analogous DNA oli-
gonucleotides and will often be less soluble.
Dissolving PNA stocks at pH ≤5.0 and heating
solutions prior to use should alleviated this. The
authors routinely check the concentration of
PNA stocks by monitoring their absorbance at
260 nm to ensure that the expected concentra-
tion is being maintained.
Table 4.11.1 Advantages and Disadvantages of Peptide Nucleic Acids
Advantages Disadvantages
Synthesis by standard peptide synthesis
protocols
Less soluble than DNA or RNA
Easy to derivatize at N or C terminus Tendency for some sequences to aggregate
High-affinity hybridization Requires carrier DNA and lipid for delivery
into mammalian cells or attachment to import
peptides
High rates of hybridization
Exceptional potential for strand invasion
Low potential for binding to proteins that bind
negatively charged polymers
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Anticipated Results
The authors’ laboratory has made several
hundred PNAs. When the Expedite synthesizer
is working properly and when all reagents are
fresh and dry, an excellent yield of the desired
product is almost invariably achieved. Crude
material before purification contains ≥50% de-
sired product, while HPLC-purified product
contains >90%. PNAs and PNA-peptide conju-
gates that require as many as 40 coupling steps
can be synthesized in good yield. It is possible
to synthesize PNAs with long runs of purines
or PNAs that are self-complementary as long
as critical coupling steps are repeated. PNA
synthesis is actually easier than peptide synthe-
sis because the “personalities” of only four,
rather than twenty, monomers are involved in
determining coupling efficiency. With care, al-
most any PNA can be obtained.
Time Considerations
Preparing the reagents for automated or
manual PNA synthesis requires 1 to 2 hr. Auto-
mated PNA synthesis can be completed within
hours, depending on the length of the PNA.
Manual synthesis should take no more than 1
hr per cycle depending on whether a capping
step is performed. Deprotection and purifica-
tion can be accomplished in 1 day. HPLC analy-
sis and purification should take 2 to 3 hr com-
bined. MALDI-TOF-MS should require no
more than 30 min.
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